Macalipay, Aileen .
HRN: 23-28-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2023
CEFUROXIME 1.5GM (VIAL)
06/30/2023
07/07/2023
IV
1.5gm
Q8
Sp Salpingectomy
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes